Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Aasebø

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Current Medicinal Chemistry|April 30, 2019
An Overview on G Protein-coupled Receptor-induced Signal Transduction in Acute Myeloid LeukemiaFrode Selheim, Elise Aasebø, Catalina Ribas, et al.
Cancers|January 11, 2024
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5Frode Selheim, Elise Aasebø, Øystein Bruserud, et al.
Expert Review of Hematology|November 24, 2017
Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemiaElise Aasebø, Sushma Bartaula-Brevik, Maria Hernandez-Valladares, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2015
Interpretation of Quantitative Shotgun Proteomic DataElise Aasebø, Frode S Berven, Frode Selheim, et al.
Expert Opinion on Drug Discovery|July 28, 2017
Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategiesØystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, et al.
Aging|December 22, 2020
Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulationMaria Hernandez-Valladares, Elise Aasebø, Frode Berven, et al.
Proteomes|February 21, 2025
Proteomic Comparison of Acute Myeloid Leukemia Cells and Normal CD34<sup>+</sup> Bone Marrow Cells: Studies of Leukemia Cell Differentiation and Regulation of Iron Metabolism/FerroptosisFrode Selheim, Elise Aasebø, Håkon Reikvam, et al.
International Journal of Molecular Sciences|May 25, 2024
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 MutationsFrode Selheim, Elise Aasebø, Håkon Reikvam, et al.
Current Pharmaceutical Biotechnology|August 27, 2015
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsElise Aasebø, Rakel B Forthun, Frode Berven, et al.
Proteomes|March 2, 2017
Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid LeukemiaMaria Hernandez-Valladares, Elise Aasebø, Frode Selheim, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Current Medicinal Chemistry|April 30, 2019
An Overview on G Protein-coupled Receptor-induced Signal Transduction in Acute Myeloid LeukemiaFrode Selheim, Elise Aasebø, Catalina Ribas, et al.
Cancers|January 11, 2024
High Mitochondrial Protein Expression as a Potential Predictor of Relapse Risk in Acute Myeloid Leukemia Patients with the Monocytic FAB Subtypes M4 and M5Frode Selheim, Elise Aasebø, Øystein Bruserud, et al.
Expert Review of Hematology|November 24, 2017
Vacuolar ATPase as a possible therapeutic target in human acute myeloid leukemiaElise Aasebø, Sushma Bartaula-Brevik, Maria Hernandez-Valladares, et al.
Methods in Molecular Biology (Clifton, N.J.)|December 25, 2015
Interpretation of Quantitative Shotgun Proteomic DataElise Aasebø, Frode S Berven, Frode Selheim, et al.
Expert Opinion on Drug Discovery|July 28, 2017
Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategiesØystein Bruserud, Elise Aasebø, Maria Hernandez-Valladares, et al.
Aging|December 22, 2020
Biological characteristics of aging in human acute myeloid leukemia cells: the possible importance of aldehyde dehydrogenase, the cytoskeleton and altered transcriptional regulationMaria Hernandez-Valladares, Elise Aasebø, Frode Berven, et al.
Proteomes|February 21, 2025
Proteomic Comparison of Acute Myeloid Leukemia Cells and Normal CD34<sup>+</sup> Bone Marrow Cells: Studies of Leukemia Cell Differentiation and Regulation of Iron Metabolism/FerroptosisFrode Selheim, Elise Aasebø, Håkon Reikvam, et al.
International Journal of Molecular Sciences|May 25, 2024
Monocytic Differentiation of Human Acute Myeloid Leukemia Cells: A Proteomic and Phosphoproteomic Comparison of FAB-M4/M5 Patients with and without Nucleophosmin 1 MutationsFrode Selheim, Elise Aasebø, Håkon Reikvam, et al.
Current Pharmaceutical Biotechnology|August 27, 2015
Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia PatientsElise Aasebø, Rakel B Forthun, Frode Berven, et al.
Proteomes|March 2, 2017
Selecting Sample Preparation Workflows for Mass Spectrometry-Based Proteomic and Phosphoproteomic Analysis of Patient Samples with Acute Myeloid LeukemiaMaria Hernandez-Valladares, Elise Aasebø, Frode Selheim, et al.
Pageof 4